Clinical Trial Update: Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant radiotherapy combined with toripalimab for locally advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN